Your browser doesn't support javascript.
Unexpected long-term survival in an adult patient with metastatic prostate cancer.
Antonov, P; Raycheva, G; Popov, V.
  • Antonov P; Medical University, Plovdiv, Bulgaria.
  • Raycheva G; Clinic of Urology, University Hospital "St. George", Plovdiv, Bulgaria.
  • Popov V; Medical University, Plovdiv, Bulgaria.
Urol Case Rep ; 37: 101634, 2021 Jul.
Article in English | MEDLINE | ID: covidwho-1213231
ABSTRACT
According to statistics, the 5-year overall survival in metastatic prostate cancer is about 21 months. We present a case of a patient with castration-resistant prostate cancer with proven bone lesions 2 years after the onset of the disease and the current survival of over 9 years.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Prognostic study Language: English Journal: Urol Case Rep Year: 2021 Document Type: Article Affiliation country: J.eucr.2021.101634

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Prognostic study Language: English Journal: Urol Case Rep Year: 2021 Document Type: Article Affiliation country: J.eucr.2021.101634